Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

RATHLIN THERAPEUTICS LIMITED

Company number 14373522

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
25 Sep 2024 CH01 Director's details changed for Dr Mary Brigid Kerr on 25 September 2024
25 Sep 2024 CS01 Confirmation statement made on 22 September 2024 with updates
23 Jul 2024 SH01 Statement of capital following an allotment of shares on 16 July 2024
  • GBP 288.56901
28 Jun 2024 AA Accounts for a small company made up to 31 December 2023
02 May 2024 CH01 Director's details changed for Dr Mary Brigid Kerr on 1 May 2024
08 Apr 2024 PSC01 Notification of Mary Brigid Kerr as a person with significant control on 12 March 2024
08 Apr 2024 PSC09 Withdrawal of a person with significant control statement on 8 April 2024
08 Apr 2024 RP04SH01 Second filing of a statement of capital following an allotment of shares on 14 March 2024
  • GBP 286.07601
26 Mar 2024 SH01 Statement of capital following an allotment of shares on 14 March 2024
  • GBP 426.70102
  • ANNOTATION Clarification a second filed SH01 was registered on 08/04/2024.
12 Oct 2023 CS01 Confirmation statement made on 22 September 2023 with updates
12 Oct 2023 PSC08 Notification of a person with significant control statement
12 Oct 2023 PSC07 Cessation of Mary Brigid Kerr as a person with significant control on 1 September 2023
07 Oct 2023 RESOLUTIONS Resolutions
  • RES13 ‐ New class of shares 31/08/2023
  • RES10 ‐ Resolution of allotment of securities
  • RES01 ‐ Resolution of adoption of Articles of Association
03 Oct 2023 MA Memorandum and Articles of Association
15 Sep 2023 AP01 Appointment of Dr Iain Dukes as a director on 1 September 2023
14 Sep 2023 AP01 Appointment of Geert-Jan Mulder as a director on 1 September 2023
14 Sep 2023 AP01 Appointment of Julen Oyarzabal as a director on 1 September 2023
05 Sep 2023 SH01 Statement of capital following an allotment of shares on 1 September 2023
  • GBP 240.62501
21 Aug 2023 SH02 Sub-division of shares on 15 August 2023
16 Aug 2023 PSC04 Change of details for Dr Mary Brigid Kerr as a person with significant control on 15 August 2023
16 Aug 2023 SH01 Statement of capital following an allotment of shares on 15 August 2023
  • GBP 100
15 Aug 2023 AA01 Current accounting period extended from 30 September 2023 to 31 December 2023
11 Apr 2023 CH01 Director's details changed for Dr Mary Brigid Kerr on 11 April 2023
11 Apr 2023 PSC04 Change of details for Dr Mary Brigid Kerr as a person with significant control on 11 April 2023
23 Sep 2022 NEWINC Incorporation
Statement of capital on 2022-09-23
  • GBP 1